Work

Choosing the Best Trastuzumab-Based Adjuvant Chemotherapy Regimen: Should We Abandon Anthracyclines?

Year: 2012

Type: article

Abstract: Journal Article

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.42.0695

Authors: Harold J. Burstein, Martine J. Piccart-Gebhart, Edith A. Perez, Gabriel N. Hortobagyi, Norman Wolmark, Kathy S. Albain, Larry Norton, Eric P. Winer, Clifford A. Hudis

Institutions: Harvard University, Dana-Farber Cancer Institute, Institut Jules Bordet, Mayo Clinic in Florida, The University of Texas MD Anderson Cancer Center, Allegheny General Hospital, Loyola University Chicago, Memorial Sloan Kettering Cancer Center

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2141912732

FWCI: 3.934

Cites: 20

Cited by: 43

Related to: 10